bioAffinity prices $2.66M registered direct offering and concurrent private placement of common stock and warrants

bioAffinity Technologies, Inc.

Offering includes 2,048,294 shares at $1.30 per share and warrants to buy up to 2,662,782 shares at $1.50.
Gross proceeds expected ~$2.66M; closing on or about Oct. 21, 2024; WallachBeth Capital acting as placement agent (8% fee).
Warrants exercisable upon stockholder approval and expire in five years; officers/directors subject to 60-day lock-up.
Bylaws amended to set quorum at 34% of outstanding shares entitled to vote, effective Oct. 17, 2024.
Shares offered under effective S-3 shelf; warrants issued in private placement exempt from registration.

item 1.01 item 3.02 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

bioAffinity Technologies, Inc.: Amended quorum requirement to 34% of outstanding shares entitled to vote (effective 2024-10-17).

Change: bylaw amendment
Effective: 2024-10-17

Exact text from the filing

On October 17, 2024, the Board amended the Company’s Amended and Restated By-Laws, effective October 17, 2024, in order to amend the quorum requirement of Article II, Section 2.07 of the Amended and Restated By-Laws, such that thirty-four percent (34%) of the outstanding shares of stock of the Company entitled to vote at the meeting, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders.

View on SEC.gov

Browse all governance changes →

bioAffinity Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-041721

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.